Behind an OKC biotech startup’s ‘facility of the future’

Local biotech startup Wheeler Bio is poised to start manufacturing batches of molecules this fall, after settling into what it calls the facility of the future.

Wheeler Bio is a contract development and manufacturing organization, or CDMO, that specializes in batch clinical production of biologics and Good Manufacturing Process-grade, or GMP, reagents using an open-source platform.

The company, launched in 2021 by CEO Jesse McCool along with co-founder Christian Kanady, is a part of Oklahoma City’s growing biotech hub, housed in the 35,000-square-foot Ziggurat building in downtown Oklahoma City.

Read more at Wheeler Bio

Share

Related Posts